Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)

SHE:301301 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	624.17	760.94	1,632	510.05	510.2	174.31
Trading Asset Securities	0.61	-	1.15	1.21	0.42	-
Cash & Short-Term Investments	624.79	760.94	1,633	511.26	510.62	174.31
Cash Growth	-43.31%	-53.41%	219.44%	0.13%	192.94%	18.01%
Accounts Receivable	2,183	1,403	1,417	1,178	1,220	1,297
Other Receivables	1.38	0.63	2.59	1.19	1.73	37.05
Receivables	2,185	1,404	1,420	1,179	1,222	1,334
Inventory	896.83	1,676	1,384	1,453	1,449	1,422
Other Current Assets	381.93	114.94	91.25	72.12	134.88	181.64
Total Current Assets	4,088	3,956	4,528	3,216	3,316	3,113
Property, Plant & Equipment	6,102	5,870	5,539	5,920	6,293	6,430
Long-Term Investments	41.22	6.78	6.93	-	-	-
Goodwill	1.37	1.37	1.37	1.37	1.37	1.37
Other Intangible Assets	241	257.99	283.07	271.83	211.54	229.57
Long-Term Deferred Tax Assets	28.26	21.65	11.34	6.96	4.02	11.17
Long-Term Deferred Charges	1.76	2.42	3.4	4.72	39.93	25.17
Other Long-Term Assets	47.55	21.64	17.97	40.94	54.46	85.14
Total Assets	10,551	10,139	10,390	9,462	9,920	9,895
Accounts Payable	689	479.98	282.99	427.66	420.63	211.63
Accrued Expenses	26.69	31.57	66.32	20.7	23.09	23.9
Short-Term Debt	320.18	850.68	978.83	700.35	790.75	4,773
Current Portion of Long-Term Debt	699.54	538.36	847.26	878.17	628.27	-
Current Portion of Leases	-	3.8	1.88	1.02	-	-
Current Income Taxes Payable	117.14	36.52	24.79	0.14	0.17	2.03
Current Unearned Revenue	77.65	28.94	38	21.26	15.78	6.55
Other Current Liabilities	66.81	565.85	467.33	513.58	521.87	438.31
Total Current Liabilities	1,997	2,536	2,707	2,563	2,401	5,456
Long-Term Debt	393	357.33	1,428	2,092	2,846	-
Long-Term Leases	473.06	188.12	10.2	3.13	-	-
Long-Term Unearned Revenue	93.5	83.74	34.24	26.22	7.92	7.92
Long-Term Deferred Tax Liabilities	0.14	0.31	0.08	-	-	-
Other Long-Term Liabilities	5.47	0.08	-	-	-	-
Total Liabilities	2,962	3,165	4,180	4,684	5,254	5,464
Common Stock	2,227	2,223	2,223	2,000	2,000	4,000
Additional Paid-In Capital	3,281	3,252	3,229	2,431	2,431	410.12
Retained Earnings	2,062	1,486	752.21	340.7	229.35	20.81
Total Common Equity	7,570	6,960	6,204	4,771	4,660	4,431
Minority Interest	18.84	12.87	6	6	6	-
Shareholders' Equity	7,589	6,973	6,210	4,777	4,666	4,431
Total Liabilities & Equity	10,551	10,139	10,390	9,462	9,920	9,895
Total Debt	1,886	1,938	3,266	3,675	4,265	4,773
Net Cash (Debt)	-1,261	-1,177	-1,633	-3,163	-3,754	-4,599
Net Cash Per Share	-0.56	-0.53	-0.83	-1.70	-1.88	-
Filing Date Shares Outstanding	2,227	2,223	2,223	2,000	2,000	-
Total Common Shares Outstanding	2,227	2,223	2,223	2,000	2,000	-
Working Capital	2,091	1,421	1,820	653.24	915.35	-2,343
Book Value Per Share	3.40	3.13	2.79	2.39	2.33	-
Tangible Book Value	7,328	6,701	5,920	4,498	4,447	4,200
Tangible Book Value Per Share	3.29	3.01	2.66	2.25	2.22	-
Buildings	-	2,779	2,637	2,560	2,461	2,397
Machinery	-	5,861	5,815	5,725	5,449	5,151
Construction In Progress	-	537.8	60.12	96.38	356.08	384.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.